ResearcherUnion HospitalActive in the last 2 years
Wen Shi
Matched on ORCID iD 0000-0002-2483-6123; OpenAlex author ID A5053438827. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2016: 2 papers · 2017: 2 papers · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper
Papers 9
- Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft models across serial passages. Co-author DOI 10.1186/s12967-025-06787-7↗
- Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding primary tumor. Co-author DOI 10.1186/s12885-024-12193-x↗
- High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fendo.2023.1181538↗
- Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer. Co-author DOI 10.3389/fphar.2023.1193791↗
- Understanding metabolomic characteristics of pancreatic ductal adenocarcinoma by HR-MAS NMR detection of pancreatic tissues. First author DOI 10.1016/j.jpba.2020.113546↗
- Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling. Co-author DOI 10.1186/s12885-017-3703-9↗
- Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer. First author DOI 10.18632/oncotarget.18057↗
- Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for … Co-author DOI 10.1039/c6mb00381h↗
- Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats. Co-author DOI 10.1111/cas.12939↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Heguang Huang · 9 shared papers, 2016–2025 · strength 1.22
- Paper Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft mode… DOI 10.1186/s12967-025-06787-7↗
- Paper Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding prim… DOI 10.1186/s12885-024-12193-x↗
- Paper High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreati… DOI 10.3389/fendo.2023.1181538↗
- Xianchao Lin · 7 shared papers, 2016–2025 · strength 0.91
- Paper Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft mode… DOI 10.1186/s12967-025-06787-7↗
- Paper Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding prim… DOI 10.1186/s12885-024-12193-x↗
- Paper Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreati… DOI 10.3389/fphar.2023.1193791↗
- Jianghua Feng · 7 shared papers, 2016–2025 · strength 0.88
- Paper Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft mode… DOI 10.1186/s12967-025-06787-7↗
- Paper Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding prim… DOI 10.1186/s12885-024-12193-x↗
- Paper Understanding metabolomic characteristics of pancreatic ductal adenocarcinoma by HR-MAS NMR detection of pancreatic tis… DOI 10.1016/j.jpba.2020.113546↗
- Yu Pan · 3 shared papers, 2023–2024 · strength 0.56
- Paper Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding prim… DOI 10.1186/s12885-024-12193-x↗
- Paper High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreati… DOI 10.3389/fendo.2023.1181538↗
- Paper Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreati… DOI 10.3389/fphar.2023.1193791↗
- Bohan Zhan · 4 shared papers, 2016–2024 · strength 0.44
- Paper Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding prim… DOI 10.1186/s12885-024-12193-x↗
- Paper Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling. DOI 10.1186/s12885-017-3703-9↗
- Paper Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer. DOI 10.18632/oncotarget.18057↗
- Pengfei Guo · 2 shared papers, 2020–2025 · strength 0.36
- Paper Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft mode… DOI 10.1186/s12967-025-06787-7↗
- Paper Understanding metabolomic characteristics of pancreatic ductal adenocarcinoma by HR-MAS NMR detection of pancreatic tis… DOI 10.1016/j.jpba.2020.113546↗
- Zelin Hou · 2 shared papers, 2023 · strength 0.34
- Paper High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreati… DOI 10.3389/fendo.2023.1181538↗
- Paper Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreati… DOI 10.3389/fphar.2023.1193791↗
- Jiajing Lin · 2 shared papers, 2023 · strength 0.34
- Paper High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreati… DOI 10.3389/fendo.2023.1181538↗
- Paper Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreati… DOI 10.3389/fphar.2023.1193791↗
- Fengchun Lu · 2 shared papers, 2023 · strength 0.34
- Paper High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreati… DOI 10.3389/fendo.2023.1181538↗
- Paper Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreati… DOI 10.3389/fphar.2023.1193791↗
- Tianhong Teng · 1 shared paper, 2025 · strength 0.23
- Minggui Pan · 1 shared paper, 2023 · strength 0.18
- Jianfeng Gao · 1 shared paper, 2023 · strength 0.18
- Sanxi Wang · 1 shared paper, 2020 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.